276 related articles for article (PubMed ID: 28125815)
1. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.
Edstedt Bonamy AK; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M;
Neonatology; 2017; 111(4):367-375. PubMed ID: 28125815
[TBL] [Abstract][Full Text] [Related]
2. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
[TBL] [Abstract][Full Text] [Related]
6. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
Isayama T; Mirea L; Mori R; Kusuda S; Fujimura M; Lee SK; Shah PS;
Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
[TBL] [Abstract][Full Text] [Related]
8. Covariation of Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Management and In-Neonatal Intensive Care Unit Outcomes Following Preterm Birth.
Hagadorn JI; Bennett MV; Brownell EA; Payton KSE; Benitz WE; Lee HC
J Pediatr; 2018 Dec; 203():225-233.e1. PubMed ID: 30243544
[TBL] [Abstract][Full Text] [Related]
9. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
[TBL] [Abstract][Full Text] [Related]
10. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
[TBL] [Abstract][Full Text] [Related]
11. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
[TBL] [Abstract][Full Text] [Related]
12. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm.
Isayama T; Kusuda S; Reichman B; Lee SK; Lehtonen L; Norman M; Adams M; Bassler D; Helenius K; Hakansson S; Yang J; Jain A; Shah PS;
J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968
[TBL] [Abstract][Full Text] [Related]
14. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants.
Rozé JC; Cambonie G; Marchand-Martin L; Gournay V; Durrmeyer X; Durox M; Storme L; Porcher R; Ancel PY;
JAMA; 2015 Jun 23-30; 313(24):2441-8. PubMed ID: 26103028
[TBL] [Abstract][Full Text] [Related]
15. Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study.
Chen HL; Yang RC; Lee WT; Lee PL; Hsu JH; Wu JR; Dai ZK
BMC Pediatr; 2015 Oct; 15():167. PubMed ID: 26496854
[TBL] [Abstract][Full Text] [Related]
16. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.
Härkin P; Marttila R; Pokka T; Saarela T; Hallman M
J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2576-2583. PubMed ID: 28651469
[TBL] [Abstract][Full Text] [Related]
17. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
[TBL] [Abstract][Full Text] [Related]
18. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
[TBL] [Abstract][Full Text] [Related]
20. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
